Quince Therapeutics, Inc. (QNCX) Dividend History

Quince Therapeutics, Inc. (QNCX) is a biotechnology company focused on developing therapies for bone-related disorders. It aims to address unmet medical needs by advancing innovative treatments targeting bone regeneration and repair.

611 Gateway Blvd., Suite 273, South San Francisco, CA, 94080
Phone: 415-910-5717
Website: https://www.quincetx.com

Dividend History

Quince Therapeutics, Inc. currently does not pay dividends

Company News

  • Quince Therapeutics and XBiotech are included in this Analyst Blog.

    Zacks Investment Research
    Featured Companies: XBIT
  • The Dow Jones closed higher by over 60 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. SHF Holdings The Trade: SHF Holdings, Inc. (NASDAQ: SHFS) Chief Legal Officer Donald Emmi acquired a total of 66,000 shares an average price of $0.87. To acquire these shares, it cost around $57,420. The company’s CEO also bought 20,000 shares of the company. What’s Happening: On Nov. 14, SHF Hldgs posted a loss for ...

    Benzinga
    Featured Companies: SHFS SILO UPXI
  • Here's how to understand what components drive value with penny stocks The post The Anatomy of Penny Stocks: Understanding What Drives Value appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    PennyStocks
    Featured Companies: CISO
Page data last updated 07/23/2025 20:15:34 UTC